Emerging infectious diseases have captured the world\'s attention. The SARS outbreak and existing threats of pandemic influenza and bioterrorism have made us realize and be aware of the fact that new infectious diseases may emerge at any time and in any place. Emerging diseases transcend species barriers, both human and animal, and obey no national boundaries.

The boom in livestock production and globalization, with an enormous increase in free trade of animals and food products compounded by modern living conditions and low hygiene in economically weaker regions of the world, ensures that factors responsible for disease emergence are in plenty. Major responsible factors include ecological changes, such as changes due to agriculture or economic development or to anomalies in climates; human demographic changes and behavior; travel and commerce; technology and industry; microbial adaptation and change; and the breakdown of public health measures. Epidemiological studies currently do not predict accurately many emerging new pathogens. Only the evolutionary perspectives provide us rough theoretical estimates for selective processes in pathogen populations. Surveillance and monitoring thus remain the most important methods to recognize and detect early new diseases. In light of the complexity and diversity of likely new emerging diseases, such surveillance should be targeted toward early recognition of disease syndromes rather than at identifying microbial diseases. The complex and rapid developments in international trade coupled with an increased demand for abundant as well as inexpensive food originating from animals or animal products, demand careful attention from both veterinary as well as human health officials. There exists a huge potential for the study of zoonosis among related professionals as we understand the science of emerging diseases, especially under the current observation that among the 60 viral species reported to be associated with bats, 59 are RNA viruses, which are potentially important in the generation of emerging and reemerging infections in humans. The prime examples of these are the lyssaviruses and Henipavirus. The transmission of Nipah, Hendra, and perhaps SARS coronavirus and Ebola virus to humans may involve intermediate amplification hosts, such as bats, pigs, horses, civets, and primates. Understanding the natural reservoir or introductory host, the amplifying host, the epidemic center, and at‐risk human populations are crucial in the control of emerging zoonosis. Particular species of bats have now been shown to promote coevolution between specific viruses and bat hosts, with the risk of cross‐infection being able to generate new viruses that are capable of jumping the transmammalian species barrier more efficiently.

This volume aims at understanding the biology of some of the newly emerging viruses and their evolution. The H5N1 outbreaks of 1997 and 2004 are early warnings of the emergence of a pandemic. Good understanding of the basic biology of this virus and its evolutionary profiles is the key to combating huge uncontrollable influenza A outbreaks. The SARS‐coronavirus has been a warning signal of the emergence of new uncontrollable viruses that show easy human--human transmission. With the potential to spread to large‐scale proportions, there is a lot to learn from this "dress rehearsal" for a pandemic virus. Nipah virus showed traditional bat to pig to human transmission, until recently, whereas in Bangladesh direct bat to human, and human to human transmission was observed with higher fatality rates than SARS and H5N1. This phenomenon clearly needs to be studied, and the biology of the virus needs to be better understood.

Human metapneumoviruses have now been detected worldwide, causing severe respiratory tract illnesses primarily in the very young, the elderly, and immunocompromised individuals. Animal models and reverse genetic techniques have resulted in the first vaccine candidates to be developed; however, considerable genetic and antigenic diversity has been observed for human metapneumovirus, and the implications of this diversity for vaccine development and virus epidemiology require further study of the basic biology of the virus. Ross River virus‐induced joint and muscle inflammation studies have been the focus of many laboratories worldwide until recently, with the development of a mouse model for study of the mechanisms behind this phenomenon, as described in this volume.

As emphasized earlier, proper surveillance and analysis and high throughput detection are described for West Nile virus in this book. Also, the use of PCR followed by electrospray ionization mass spectrometry, as well as newer approaches to vaccine development, using plants as bioreactors for vaccines, are some of the latest concepts briefly introduced in this volume. Although by no means exhaustive, our hope is that this volume will introduce or update the readership on the latest developments in the respective fields described above.
